A good website attracts users’ attention, elaborates on the topic, and gives a positive impression. Websites about disorders and diseases are not an exception: they must provide people with a clear explanation of the issue in plain language for everyone to understand the topic. The Attention Deficit Disorder Association is an example of a medical website that caters to the medical field, specifically regarding attention deficit disorder. While a good website has a good interface that makes using it convenient and pleasant, the Attention Deficit Disorder Association meets these criteria and provides its readers with medical information about ADHD in an understandable way.
A good website must meet specific requirements that appeal to aesthetics and content to establish relevance with its base audience. The language used must be plain and adequate explanations for every medical term provided. Moreover, the services the website offers need to appeal to a wide variety of people. A medical website must allay the information in language that does not scare its demographic while maintaining accuracy. Furthermore, a good interface design is fundamental for success. Any webpage needs a simple organization that is appealing to perceive. The colors need to be appropriate, and the hierarchical structure implemented according to web design rules. It must be functional and consist of sections dedicated to the in-depth exploration of the subject matter.
The Attention Defect Disorder Association (ADDA) website offers the public information on Attention Deficit Disorder (ADD). The ADDA site meets the criteria of a good website by providing its users with courses that educate them on ADD. Additionally, the page explains the differences between ADD and ADHD because people frequently confuse the two concepts. In all sections, the ADDA website is informative and conveniently subdivided. Opening and scrolling the page “ADHD: the facts” reveals to a user a concise definition of ADHD that is written in plain language and is undoubtedly clear (ADHD, 2022). Then, the authors explain who has the condition, elaborate on the symptoms, and provide users with a clear understanding of the diagnosis.
ADHD is a brain disorder characterized by inattention and hyperactivity. Attention deficit is diagnosable in children under 16; however, the symptoms and resultant consequences can persist into adulthood. Symptoms such as inattention affect schoolwork and critically make the patient seem disorganized or careless. AlAzzam et al. assert that schoolteachers in Jordan have developed a negative perspective of the condition due to a lack of training in childhood behavioral problems (2021). This attitude percolates into assessment tests and adversely affects the child’s performance and development. The ADDA website clearly defines the differences between ADD and ADHD, providing the reader with a clear scope of the medical condition.
ADDA is particularly informative and offers targeted assistance to people with attention deficit disorder. Furthermore, the ADDA website advises people with ADHD on possible ways to alleviate and treat the symptoms. The site elaborates on how a doctor makes the diagnosis, what tests a patient will pass, and what information a specialist can gather. Furthermore, the page writes about treatment and medication for such patients. Such information is not helpful for the target audience and may not interest or help them.
Recently, there have been developments in drugs concerning the treatment of hyperactivity disorder. In particular, Singh et al. (2022) support using Viloxazine, a clinically tested drug to alleviate attention deficit disorder symptoms. The drug test involved a control group of 1605 pediatric patients aged 6 to 17 (Singh et al., 2022). Viloxazine proved successful compared to its placebo counterparts, and its efficacy rates support its success as a possible treatment. Furthermore, the website offers the users to participate in volunteering to help individuals with the condition. ADDA provides people with detailed and comprehensive information about ADHD treatment and educates them on the various possible options. However, the medical site does not define who can benefit from courses and the target audience.
In conclusion, ADDA provides the target audience with concise and transparent information about ADHD, explaining it in plain language from different perspectives. Its interface is highly convenient and well structured. Attention deficit disorder is tough to deal with and manifests in children under 16. As outlined by AlAzzam et al., Jordanian schoolteachers reflect society’s negative perceptions of the condition. However, through the treatment of drugs such as Viloxazine, patients can lead an ordinary life despite suffering from hyperactivity or inattention. The website consists of different parts, covers various topics, and offers services that target a broad audience and assist a wide scope of people.
References
ADHD. (2022). Adda. Web.
AlAzzam, M., Tawalbeh, L., Abu Al-Rub, M., Khamaiseh, A., ALBashtawy, M., Barahemah, M., Eyadat, M., & Poedel, R. J. (2021). Exploring elementary schoolteachers’ perceptions of attention deficit hyperactivity disorder (ADHD) in northern Jordan. Child Psychiatry & Human Development, 53(3), 538–545. Web.
Singh, A., Balasundaram, M. K., & Singh, A. (2022). Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Journal of Central Nervous System Disease, 1(1), 1–9. Web.